Two-dimensional method for time aligning liquid chromatography-mass spectrometry data.
We describe a new time alignment method that takes advantage of both dimensions of LC-MS data to resolve ambiguities in peak matching while remaining computationally efficient. This approach, Warp2D, combines peak extraction with a two-dimensional correlation function to provide a reliable alignment scoring function that is insensitive to spurious peaks and background noise. One-dimensional alignment methods are often based on the total-ion-current elution profile of the spectrum and are unable to distinguish peaks of different masses. Our approach uses one-dimensional alignment in time, but with a scoring function derived from the overlap of peaks in two dimensions, thereby combining the specificity of two-dimensional methods with the computational performance of one-dimensional methods. The peaks are approximated as two-dimensional Gaussians of varying width. This approximation allows peak overlap (the measure of alignment quality) to be calculated analytically, without computationally intensive numerical integration in two dimensions. To demonstrate the general applicability of Warp2D, we chose a variety of complex samples that have substantial biological and analytical variability, including human serum and urine. We show that Warp2D works well with these diverse sample sets and with minimal tuning of parameters, based on the reduced standard deviation of peak elution times after warping. The combination of high computational speed, robustness with complex samples, and lack of need for detailed tuning makes this alignment method well suited to high-throughput LC-MS studies.
Suits
Frank
F
IBM T. J. Watson Research Center, P.O. Box 218, Yorktown Heights, New York 10598, USA. suits@us.ibm.com
Lepre
Jorge
J
Du
Peicheng
P
Bischoff
Rainer
R
Horvatovich
Peter
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001798:Blood Proteins / Q000032:analysis; D045304:Cytochromes c / Q000032:analysis; D003627:Data Interpretation, Statistical; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006736:Horses; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D016482:Urinalysis / Q000379:methods; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000652:urine
D001798:Blood Proteins; D045304:Cytochromes c